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ABSTRACT 
Objective 
It is well established that serious mental illness is associated with raised mortality, yet few 
studies have looked at the life expectancy of people with personality disorder (PD). This 
study aims to examine the life expectancy and relative mortality in people with PD within 
secondary mental health care.  
Methods 
We set out to examine this using a large psychiatric case register in southeast London, UK. 
Mortality was obtained through national mortality tracing procedures. In a cohort of patients 
with a primary diagnosis of PD (n=1836), standardized mortality ratios (SMRs) and life 
expectancies at birth were calculated, using general population mortality statistics as the 
comparator.  
Results 
Life expectancy at birth was 63.3 years for women and 59.1 years for men with PD - 18.7 
years and 17.7 years shorter than females and males respectively in the general population in 
England and Wales.  The SMR was 4.2 (95% CI: 3.03 – 5.64) overall; 5.0 (95% CI: 3.15 – 
7.45) for females and 3.5 (95% CI: 2.17 – 5.47) for males. The highest SMRs were found in 
the younger age groups for both genders.  
Conclusion 
People with PD using mental health services have a substantially reduced life expectancy, 
highlighting the significant public health burden of the disorder.  
 
Keywords: epidemiology; life expectancy; mental health services; mortality; personality 
disorders  
 
  
 
 
 
INTRODUCTION 
Mental disorder is an established risk factor for increased mortality [1, 2]. People with mental 
disorders die prematurely for a variety of reasons, including poor physical health [3-5], 
adverse physiological consequences of long term psychotropic medication, unhealthy lifestyle 
[5], as well as increased death rates as a result of suicide, accidents and homicide [6-8].  The 
risk of increased mortality has been shown to vary according to type of mental disorder, with 
substance use disorders conferring a particularly high risk of early death [1, 9, 10]. 
Personality disorder is a global health problem [11].  It is one of the hardest psychiatric 
conditions to treat and has a considerable economic impact on general medical and mental 
health services. People with personality disorder (PD) are known to be at particularly high 
risk of increased mortality as a result of both natural and unnatural causes [12-16]. However, 
no study has comprehensively examined life expectancy at birth of the full range of secondary 
care service users with PD.  Life expectancy is a vital public health statistic which serves as a 
readily identifiable indicator of general mortality in a specified population followed up for a 
certain period of time.  
 
 
METHOD 
In the current study, we used a large psychiatric case register to conduct a retrospective cohort 
study, the purpose of which was to ascertain life expectancy at birth and age- and gender-
standardised mortality of personality-disordered patients compared to the general England and 
Wales population. We also calculated standardised mortality ratios stratified by gender and 
age group, in order to investigate differences among subgroups. 
 
Setting and Participants 
  
 
 
 
Our sample was drawn from the electronic case register of the South London and Maudsley 
NHS Foundation Trust (SLAM), Europe’s largest secondary mental health care provider 
serving an aggregate population of 1.2 million people living in four London boroughs 
(Lambeth, Southwark, Lewisham and Croydon).  The SLAM Biomedical Research Centre 
(BRC) Case Register provides anonymised in-depth information derived from an electronic 
clinical record system.  The development and protocol of this case register has been described 
in detail in a previous open access publication [17].  SLAM incorporates inpatient and 
outpatient care, and a broad array of community care teams, as well as psychiatric liaison 
services to general hospitals, and forensic, old age, child and adolescent, and learning 
disability mental health teams.   
 
Electronic clinical records have been used comprehensively across all SLAM services since 
2006 and the BRC Case Register Interactive Search (CRIS) system was developed in 2008 to 
allow searching and retrieval of anonymised information from full clinical records with over 
182,000 cases currently represented on the system. CRIS was approved as a data resource for 
secondary analysis by the Oxfordshire Research Ethics Committee (reference 08/H0606/71).  
 
All cases within the case register that had been given a primary PD diagnosis by International 
Classification of Diseases, 10
th
 Edition (ICD-10) within the four-year period from 1 January 
2007 to 31 December 2010, and were over 15 years of age, were recruited into the study as a 
cohort (n=1,836). All-cause mortality in patients with PD over this four-year period was used 
for analyses. The beginning of 2007 was chosen as a starting point for the observation 
because this corresponded to the most complete recording of clinical data on the Case 
Register. 
 
  
 
 
 
Measures 
Death identification 
NHS number is a unique identifier for UK NHS records.  All death certifications are linked to 
this identifier at national level, and health service providers are required by law to keep 
records up to date with respect to this. Every death in the UK, after the issuing of a formal 
death certificate, must be reported to the Office for National Statistics General Records Office 
and conveyed to the NHS Care Records Service, which holds these death notifications and 
makes them available to all NHS organisations.  In accordance, on a weekly basis, SLAM 
downloads a list of deceased patients from the NHS Care Records Service and updates their 
dates of death onto the patients’ records, whether that person is active to services or has been 
discharged.  In the present study, deaths determined by a date of death within the 4-year 
period were enrolled for analyses. 
 
Personality Disorder 
This was based on the patient’s primary ICD-10 diagnosis of PD (categories F60 and F61) 
dated from 1 January 2007 to 31 December 2010 in the Case Register.  
 
Demographics 
Date of birth, gender, ethnicity and marital status of all patients are routinely recorded on the 
Case Register. Age was calculated at the date of primary diagnosis of PD that occurred in the 
observation period. All those who were under the age of 15 at this date were excluded from 
the analyses.  
 
 
Statistical analysis 
  
 
 
 
Life expectancy at birth 
Life expectancy at birth is an index derived from age-specific mortality that highlights the 
impact of mortality in younger age groups.  A life table is constructed using the age-specific 
mortality of an observed population over a given period of time; life expectancy at birth is 
calculated from the accumulated total person-years contributed by the entire concurrent cohort 
divided by the size of the population at the beginning of follow up. We used Chiang’s method 
of abridged life tables with five-year age bands to calculate life expectancy [18]. For each 
individual, the period of time from the date of PD diagnosis until death or the end of the 
observation period (whichever occurred first), was taken as the ‘at-risk period’. In each 5-year 
age band, the total person-years at risk is the sum of all the at-risk periods of the individuals 
in the age band. The number of people who had a recorded death during this period was used 
as the numerator to calculate the annual mortality rate for the age band. In some instances, 
individuals moved from one age band to the next during the four-year observation period.  In 
such cases, the specific time at risk contributed by those individuals to each age band was 
then assigned to the respective age bands.  Given that those below the age of 15 years were 
excluded from our cohort, we filled in the three cells in the life table corresponding to death 
rates for 0-5 years, 5-10 years and 10-15 years of age with the respective comparative death 
rates for these age groups in the England and Wales general population in 2008 [19]. These 
tables were inserted into a Microsoft Excel spreadsheet and values for gender-specific life 
expectancy were calculated with 95% confidence intervals. These life expectancy estimates 
were compared with gender-specific life expectancy at birth for the England and Wales 
population in 2006-2008 [20], and the arithmetic differences between the two were then 
calculated. 
 
 
  
 
 
 
Standardized mortality ratios 
The estimation of all SMRs were carried out using Stata version 10 [21]. As with life 
expectancy, the at-risk period was defined as the period of time from the date of PD diagnosis 
in the observation period until date of death or the end of the observation period (whichever 
occurred first). SMRs were calculated for the four-year follow-up period, using the number of 
deaths observed in the cohort in these four years as the numerator. SMRs were gender- and 
age- standardized using five-year age bands (i.e., 15-19, 20-24, 25-29, …, 85-89, 90 or over). 
The denominator was derived by calculating the total person-years at risk in each age group 
of the sample, then multiplying this by the corresponding age- and gender -specific mortality 
rate in the England and Wales population [19]. The time period at risk contributed by 
individuals who moved from one age band to the next during the observation period, was 
assigned to the respective age bands.  
 
 
RESULTS 
A total of 1,836 cases formed the analysed cohort. The characteristics of the cases are 
displayed in Table 1. In summary, the majority were female (60%), 73% were white British 
and 74% were in the 15-44 years age group. Regarding marital status, 66% were single, 10% 
were either married, cohabiting or in a civil partnership, and 12% were divorced, separated or 
widowed. 
[ Table 1 here] 
 
Estimates of life expectancy at birth of people with PD, stratified by gender, are displayed in 
Table 2 along with differences compared to general population estimates. Compared to the 
  
 
 
 
England and Wales general population, the life expectancy of men and women with PD in this 
sample was lower by 17.7 and 18.7 years respectively. 
 
Table 3 displays age- and gender-standardized SMRs for the entire cohort and then stratified 
by gender and age groups. The SMR for all patients with PD in this cohort was 4.2 (95% CI: 
3.03 – 5.64) and the SMRs for male and female personality-disordered patients were of a 
similar magnitude. Stratification by age bands revealed that the youngest age group (15-44 
years old) carried the highest excess mortality, compared to the general population, and that 
the youngest age group had higher excess mortality compared to the oldest age group.  
[Tables 2 and 3 here] 
 
 
 
 
DISCUSSION 
Main Findings 
Our study highlights the substantial public health burden of personality disorder in terms of 
elevated mortality, especially for younger age groups. We found that patients with personality 
disorder can expect, on average, considerably shortened lives compared to their counterparts 
in the general population, with men losing 17.7 years of life and women losing 18.7 years. 
Their mortality was four times that of the comparative general population. Furthermore, a 10-
fold increased mortality risk was found for younger people with personality disorder. These 
findings critically underscore the vulnerable nature of people with PD and the urgent need for 
developing feasible strategies to prevent premature mortality in this group of patients. 
 
  
 
 
 
A number of studies have previously found an association between PD and raised mortality 
[12-16]. However, to our knowledge, our study is the first to comprehensively examine the 
life expectancy of secondary care service users with PD. Only one other study has attempted 
to describe life expectancy for people with PD. Hannerz et al [22] used a Swedish nationwide 
hospital discharge registry to estimate life expectancies in different diagnostic groups for 
individuals treated as inpatients. Both men and women with personality disorder had a lower 
“expectation of remaining life” at all ages, compared to people with schizophrenia and 
affective psychosis as well as the general population. However, the restriction of that analysis 
to hospitalised patients and the use of ICD-8 diagnoses limit the application of the findings to 
present-day secondary care settings.  Approximate estimates of life expectancy at birth can be 
calculated using SMRs from published studies [23];  however doing this from the few existing 
studies would only generate a very rough estimate for people with PD, and one which would 
be less accurate than the method used in our study. Our data contributes to the literature 
generally as well as providing UK specific data on life expectancy.  
 
Strengths and Limitations  
Our study has a number of strengths. We analysed a large sample of cases covering a broad 
age range. We included everyone with PD who had contact with services over a 4-year period, 
whether this was in the context of inpatient admission, community care or one-off emergency 
presentation. We therefore captured a wide range of patients with PD adding to the 
generalisability of our findings to other secondary care settings. The NHS setting with 
relatively comprehensive coverage provided to specific geographic catchments was also an 
advantageous setting regarding generalisability to other secondary care settings. In terms of 
diagnosis, although research diagnostic criteria may be preferable, our use of clinicians’ case 
record ICD-10 diagnoses favours generalisability to real clinical practice. The mortality data 
  
 
 
 
were derived from a robust source and under-ascertainment of deaths is likely to have been 
very low. Furthermore, any possible failures in the reporting of deaths would only have led to 
an underestimation of the detected associations.  
 
The findings need to be considered in the light of certain limitations.  First, standardized 
mortality ratios only provide a coarse picture of deaths in a specified study population without 
the consideration of confounders other than age and gender. Potentially important 
confounders which are unmeasured in this study include socio-economic status, comorbid 
psychiatric and physical conditions and substance misuse. Second, we were only able to 
report on all-cause mortality; against this, our aim was to clarify excess mortality and reduced 
life expectancy rather than investigate underlying causes of death.  Third, our statistical power 
to examine associations between PD clusters and mortality was not sufficient to detect 
significant differences. Fourth, we used national data as a comparison, which might not be 
representative of the local population in southeast London. To address this, we carried out a 
sensitivity analysis, standardising with mortality statistics for London alone (data not shown); 
in the sensitivity analysis, the point estimates for SMRs were not substantially different 
compared to those displayed in Table 3. Fifth, the observed age-related decline in SMRs may 
be due to survival effects i.e., that people with PDs surviving to older age may have other 
protective factors conferring this survival. Finally, we acknowledge that a large number of 
people with PD do not present themselves to mental health services and are either managed in 
primary care or within general medical services. Our findings therefore only apply to 
secondary mental health service users. 
 
Possible mechanisms 
A number of mechanisms are likely to underlie the detected association between PD and 
reduced life expectancy. First, the rate of death from unnatural causes, including suicide and 
  
 
 
 
homicide, is elevated in PD [6] and this is likely to have contributed to the reduced life 
expectancy detected in this study. Second, considering deaths due to natural causes, 
personality disorder is associated with poorer general health. For example, Borderline PD has 
been found to be associated with higher numbers of medical problems and one recent 
epidemiological study found that most PD groups were associated with cardiovascular disease 
[24]. More generally, mental disorders are linked to poor health through unhealthy lifestyle 
[25, 26], physical consequences of psychotropic medication [3], and problems accessing 
medical care [27]; some or all of these factors may account for reduced survival in people 
with PD. Substance use disorders are a major cause of death and disability [1, 9] and 
frequently co-occur with PD, particularly in young people with Cluster B PD [28], and the 
particularly high SMR for Cluster B PD may reflect unhealthy lifestyles characterised by 
heavy substance use and smoking. Patients with PD are often prescribed excessive doses of 
psychotropic and non-psychotropic medications [29]  which themselves may potentially lead 
to unwanted physical consequences. Finally, people with PD often struggle to obtain adequate 
health care and have greater unmet treatment needs [30].   
 
We conclude that people with PD have a significantly reduced life expectancy at birth 
compared to the general population. This fact alone highlights the importance of routinely 
assessing personality status in psychiatric patients. It also highlights the need for clinicians to 
pay greater attention to the physical health status and lifestyles of patients with PD, in 
addition to the standard practice of assessing their suicide risk. Further research is urgently 
required to determine the mechanisms underlying the reduced life expectancy of people with 
PD.  
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Table 1  Characteristics and 4-year mortality of patients with personality disorder 
Characteristics Number of PD cases (Number of deaths, %) 
  
Total cohort 1836 (43, 2.34%) 
Gender  
Female 1103 (23) 
Male 733 (20) 
Ethnicity  
White British 1340 (39) 
Mixed 29 (0) 
Asian or Asian British 41 (3) 
Black or Black British 226 (1) 
Other 84 (0) 
Not stated/Unknown  116 (0) 
Age group  
15-44 years 1354 (20) 
45-64 years 419 (11) 
65 + years 63 (12) 
Personality disorder  
Any personality disorder (F60-F61) 1836 (43) 
Cluster A (F60.0, F60.1) 109 (2) 
Cluster B (F60.2, F60.3, F60.31, F60.4) 924 (18) 
Cluster C (F60.5, F60.6, F60.7) 62 (1) 
Other 741 (22) 
 
 
Table 2  Estimated life expectancy at birth of patients with personality disorder in southeast London 
 Female Male 
 Life Expectancy (95% CI, 
number of deaths) 
Difference from female   
general population* 
Life Expectancy (95% CI, 
number of deaths) 
Difference from male 
general population* 
All 
personality 
disorders 
 
62.9 (61.5 – 64.3, n=23) -18.7 years 59.7 (57.9 – 61.5, n=20) -17.7 years 
 
*Life expectancy at birth 2006-08 in England and Wales: Female = 81.6 years; Male = 77.4 years [21] 
Table 3  Age- and gender-standardized mortality ratios (SMRs) for personality disorder, stratified by 
gender and age groups in 2007-2010 
  
Number of cases 
Standardized mortality ratio 
(95% CI, number of deaths) 
Total PD group 1836 4.2 (3.03 – 5.64, n=43 ) 
Females  1103 5.0 (3.15 – 7.45, n=23) 
Males  733 3.5 (2.17 – 5.47, n=20) 
    
Age 15 – 44 years 1354 10.3 (6.29 – 15.91, n=20) 
 45 – 64 years 419 3.6 (1.78 – 6.37, n=11) 
 65 and over 63 2.5 (1.31 – 4.43, n=12) 
 
 
